Created at	Source	Raw Value	Validated value
June 25, 2024, noon	usa	* known allergy to the study medication * is on another antiviral for the treatment of covid-19 * pregnancy * patients with severe hepatic dysfunction equivalent to grade c in the child-pugh classification * patients with renal impairment requiring dialysis * is deemed by the investigator to be ineligible for any reason	* known allergy to the study medication * is on another antiviral for the treatment of covid-19 * pregnancy * patients with severe hepatic dysfunction equivalent to grade c in the child-pugh classification * patients with renal impairment requiring dialysis * is deemed by the investigator to be ineligible for any reason
Oct. 26, 2020, 11:31 p.m.	usa	- known allergy to the study medication - is on another antiviral for the treatment of covid-19 - pregnancy - patients with severe hepatic dysfunction equivalent to grade c in the child-pugh classification - patients with renal impairment requiring dialysis - is deemed by the investigator to be ineligible for any reason	- known allergy to the study medication - is on another antiviral for the treatment of covid-19 - pregnancy - patients with severe hepatic dysfunction equivalent to grade c in the child-pugh classification - patients with renal impairment requiring dialysis - is deemed by the investigator to be ineligible for any reason